டெபோரா ரதிஜேன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Bioasis Technologies Inc appoints former PricewaterhouseCoopers veteran Dave Jenkins as chief financial officer
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Progressive Planet Solutions Inc, Real Luck Group Ltd, Deep-South Resources Inc, Kidoz Inc, Sigma Lithium Resources Corporation, Progressive Planet Solutions Inc, NEO Battery Materials Ltd, Victory Square Technologies Inc UPDAT
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Sigma Lithium Resources Corporation, Progressive Planet Solutions Inc, NEO Battery Materials Ltd, Victory Square Technologies Inc UPDATE …
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Bioasis Technologies talks its unique xB3 platform and Aposense collaboration
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Follow Patrick on:
Bioasis Technologies announces publication validating its xB3 platform to cross the intact blood-brain barrier
Data published in the Frontiers in Neuroscience provides evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB By crossing the intact BBB, the platform enters intracellular organelles within neurons, glia, and microglia in the brain
Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types.